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Abstract
In this study we exchanged portions of the poliovirus type 1 (PV1) hydrophobic domain within the membrane-associated polypeptide
3AB for the analogous sequences from human rhinovirus 14 (HRV14). The sequence exchanges were based upon a previous report in which
the 22 amino acid hydrophobic region was subdivided into two domains, I and II, the latter of which was shown to be required for membrane
association (J. Biol. Chem. 271 (1996), 26810). Using these divisions, the HRV14 sequences were cloned into the complete poliovirus type
1 cDNA sequence. RNAs transcribed from these cDNAs were transfected into HeLa cell monolayers and used in HeLa cell-free
translation/replication assays. The data indicated that 3AB sequences from PV1 and HRV14 are interchangeable; however, the substitutions
cause a range of significant RNA replication defects, and in some cases, protein processing defects. Following transfection of RNAs
encoding the domain substitutions into HeLa cell monolayers, virus isolates were harvested, and the corresponding viral RNAs were
sequenced. The sequence data revealed that for the carboxy-terminal domain substitutions (domain II), multiple nucleotide changes were
identified in the first, second, and third positions of different codons. In addition, the data indicated that for one of the PV1/HRV14 chimeras
to replicate, compensatory mutations within poliovirus protein 2B may be required.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Similar to most positive-strand RNA viruses, picornavi-
ruses amplify their genomic RNA in the context of mem-
brane-associated replication complexes (Caliguiri and
Tamm, 1969; Caliguiri and Tamm, 1970a, 1970b; Bienz et
al., 1992, 1994). All newly synthesized RNA chains have a
small, viral-encoded peptide termed VPg (or 3B) covalently
attached to their 5 termini via a phosphodiester-like linkage
(Lee et al., 1977; Flanegan et al., 1977; Rothberg et al.,
1978; Ambros and Baltimore, 1978). This protein–RNA
linkage is thought to be the result of a protein-priming
mechanism in which a uridylylated form of VPg serves as a
protein primer for the RNA-dependent RNA polymerase
(3Dpol) to initiate RNA synthesis (Nomoto et al., 1977;
Pettersson et al., 1978; Takegami et al., 1983; Paul et al.,
1998). It has been shown that the uridylylation event is
dependent, in part, upon an internal cis-acting RNA element
(cre), an element first reported for human rhinovirus (Mc-
Knight and Lemon, 1996, 1998) and subsequently found in
a number of other picornavirus genomes (Lobert et al.,
1999; Goodfellow et al., 2000; Paul et al., 2000; Gerber et
al., 2001; Mason et al., 2002). The presence of this internal
RNA hairpin appears to be essential for viral RNA synthesis
(Rieder et al., 2000; Paul et al., 2000; Yang et al., 2002;
Goodfellow et al., 2003).
VPg is a strongly basic protein (pI  10) that is utilized
in a hydrophobic environment. This has led to the hypoth-
esis that VPg is delivered to the replication machinery as
part of a larger lipophilic protein that contains the VPg
sequences (Semler et al., 1982). One candidate for such a
viral protein is poliovirus polypeptide 3AB, which contains
the VPg sequence in addition to a 22 amino acid stretch of
nonpolar residues. It was previously shown that poliovirus
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3AB associates with microsomal membranes in a manner
consistent with that of an integral membrane protein (Datta
and Dasgupta, 1994; Towner et al., 1996). Since the 22
amino acid hydrophobic domain is highly conserved among
various members of the enterovirus and rhinovirus genera
(Kitamura et al., 1981; Racaniello and Baltimore, 1981;
Stanway et al., 1984; Giachetti and Semler, 1990; Towner et
al., 1996), it is reasonable to predict a common mechanism
for VPg delivery to the replication complex. Indeed, the
idea of functional conservation within the replication ma-
chinery among members of the rhinovirus and enterovirus
genera has been recently supported by the ability to isolate
virus from chimeric poliovirus RNA possessing a VPg from
human rhinovirus 14 (HRV14), and furthermore, that the
HRV14 VPg can be uridylylated in vitro by poliovirus 3Dpol
(Paul et al., 2003).
The 22 amino acid nonpolar sequence in 3A, referred to
as the hydrophobic domain, has been further subdivided
into two smaller domains, domains I and II, in which the
hydrophobicity present in domain II was found to be essen-
tial for 3AB membrane association (Towner et al., 1996).
Interestingly, the sequences in domain I could be com-
pletely removed with no apparent effect on membrane as-
sociation. Yet single amino acid substitutions of conserved
residues within the same domain result in viruses with
severe RNA replication defects, particularly at the level of
initiation of positive-strand RNA synthesis (Giachetti and
Semler, 1991). In addition, single and multiple amino acid
substitutions of nonconserved residues in domain I or II can
result in significant in vitro protein processing defects char-
acterized by the overproduction of proteins P2 and 3BCD
and the underproduction of protein 2C (Giachetti et al.,
1992). Taken together, these results suggest that the two
adjacent domains within the hydrophobic region may be
involved in multiple structural support functions, effector
domains, or protein subunit interfaces.
There is evidence that the function(s) of the hydrophobic
domain is not completely conserved among the entero- and
rhinovirus members because multiple poliovirus and rhino-
virus mutants that have developed tolerance to the drug
enviroxime contain mutations within 3AB (or 3A, the same
polypeptide without VPg amino acid sequences at its car-
boxy-terminus) that are consistently clustered in different
regions of the protein. The drug tolerant mutations in
HRV14 tend to involve charged residues in the middle of
3AB, while the analogous phenotypic changes in poliovirus
are consistently clustered within the hydrophobic domain
(Heinz and Vance, 1995, 1996). Therefore, to determine if
the entire hydrophobic domain, or only a portion thereof, is
functionally conserved among members of the entero- and
rhinovirus genera, the analogous sequences within the
HRV14 hydrophobic domain were substituted in multiple
combinations for the corresponding sequences within polio-
virus protein 3AB. While the overall hydrophobicity of the
22 amino acid hydrophobic domain is well conserved, the
identity at the amino acid level is less than 50%. These
chimeric PV1/HRV14 3AB sequences were then placed in
the poliovirus type 1 background and assayed for infectivity
as well as RNA synthesis in both HeLa cells and in a
poliovirus cell-free translation/replication assay. In this
study, we report that the HRV 14 domain I substitution
within 3AB results in an infectious RNA, while those chi-
meras containing domain II substitutions are quasi-infec-
tious. Multiple reversion mutants were isolated, including
one with a second site lesion in poliovirus protein 2B.
Results
In vitro translation and RNA replication
As an initial assessment of RNA synthesis and protein
processing in the absence of the multiple rounds of genetic
selection and amplification that take place in infected cells,
each of the full-length RNAs harboring the domain substi-
tutions (Fig. 1) was translated and replicated in a HeLa
cell-free translation/replication assay. The results of this
analysis are displayed in Fig. 2. Fig. 2A shows the transla-
tion and protein processing directed by each RNA, while
Fig. 2B shows the corresponding in vitro RNA replication
assays. As shown in lanes 3 and 5 of Fig. 2A, a slight defect
in protein processing can be seen when compared to that of
wild-type for PV RNAs containing the HRV14 domain I or
domain III sequences. This defect is characterized by a
small increase in 3BCD and corresponding decrease in
3Dpol. Compared to wild-type, the substitution of HRV14
domain II sequences does not result in any protein process-
ing defect (compare lane 4 to lane 2). In all cases, the
domain substitutions confer significant electrophoretic mo-
bility differences upon the 3AB protein compared to wild-
type.
When the level of primary RNA replication by each of
the mutants was measured in vitro, significant differences
among them were evident. As shown in Fig. 2B, lane 4, the
substitution of the domain I sequences results in a signifi-
cant RNA replication defect compared to wild-type (lane 3)
at the level of synthesis of both single-stranded and repli-
cative intermediate/replicative form RNAs. This defect in
RNA synthesis by DIS may be due to the protein processing
defect (a processing defect potentially causing decreased
levels of 3Dpol). Interestingly, the DIIS RNA, which directs
wild-type-like protein processing, replicates at even lower
levels than the DIS RNA, indicating that the HRV14 do-
main II sequences likely confer a true RNA synthesis defect.
Finally, as shown in Fig. 2B (lane 6), substitution of the
entire HRV14 hydrophobic domain, except for the first five
amino acids at the N-terminal portion, results in a dramatic
RNA replication defect. The defect in RNA replication may
be due, in part, to the above-described protein processing
defect. It is noteworthy that little 3AB can be seen in lane 5
of Fig. 2A, although it can be seen after long exposures of
the autoradiograph (data not shown).
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Transfection of HeLa cells and plaque isolation
To determine if the HRV14 sequence substitutions into
the PV 3AB hydrophobic domain (outlined in Fig. 1) result
in the generation of infectious viruses, transcribed RNAs
corresponding to wild-type PV1 and each domain substitu-
tion were separately transfected into HeLa cell monolayers
at 33 and 37°C. Each RNA was transfected in duplicate at
the concentrations of 5, 0.5, 0.05, and 0.005 g per 60-mm-
diameter dish and overlaid with semisolid or liquid media.
At 48, 72, 96, and 120 h after transfection, the plates were
examined for cytopathic effect (CPE), plaque size, and
plaque number. The results of the RNA transfection exper-
iment are summarized in Table 1. RNAs encoding the do-
main I substitution had a specific infectivity similar to that
of wild-type RNA as evidenced by the appearance of equal
numbers of plaques per microgram of RNA. At 37°C, the
plaques generated from the DIS RNA were heterogeneous
in size but were consistently smaller than those of wild-type
poliovirus. In contrast, transfection of both the DIIS and the
D(III)S RNAs resulted in 100- to 1000-fold fewer plaques
per microgram of RNA compared to that of either wild-type
or DIS. Nearly identical results were seen for those trans-
fection assays carried out at 33°C with the exception that the
overall growth kinetics for wild-type PV1 and all three
domain substitutions were delayed by approximately 12–24
h (data not shown). Based upon the similar transfection
results for each RNA at 33 C versus 37°C, only plaques
isolated at 37°C were chosen for expansion and further
analysis. Primary plaques present on the wild-type and DIS
plates at 37°C were harvested at 48 and 72 h, while the
plates for both DIIS and D(III)S were incubated for an
additional 24 to 48 h prior to plaque isolation. For each
domain substitution, three primary plaques were used for a
second round of plaque purification.
Primary transfections in which the monolayers were
overlaid with liquid media were carried out three separate
times with each experiment yielding consistent times for the
onset of CPE. In only one experiment were HeLa monolay-
ers additionally overlaid with semisolid media for the pur-
pose of harvesting primary plaques directly following the
RNA transfection. A summary of the isolates harvested and
time for the onset of CPE for each of the domain substitu-
tions is presented in Table 2. Based upon these data, the
domain I substitution appears to be infectious, while the
domain II and domain III substitutions appear to be quasi-
infectious.
Nucleotide sequences of recovered virus isolates
Following secondary plaque purifications, each plaque
was used to generate passage 1 (P1) and passage 2 (P2)
virus stocks. HeLa cell monolayers were infected with 0.5
ml of P1 stock, and total RNA was harvested at the time of
onset of CPE. In contrast to the pronounced differences in
the kinetics of appearance of CPE following transfection of
Fig. 1. Nucleotide sequences and amino acid substitutions of the hydrophobic domain of 3AB. The nucleotide sequences (as cDNA) and amino acids of the
poliovirus hydrophobic domain are aligned with the analogous sequences of human rhinovirus. Below each of the PV1 and HRV14 sequences are the amino
acid substitutions in which DIS indicates the substitution of HRV14 sequences for those of PV1 between the PstI and BglI sites (domain I), while DIIS
indicates the substitution of the analogous HRV sequences for those of PVI between the BglI and HindIII sites (domain II). D(III)S indicates the substitution
of the HRV sequences between the PstI and HindIII sites (domains III). Boxed regions in gray outline the restriction sites used for the mutagenesis where
both the PstI and the HindIII sites contain genetically engineered silent mutations to create the restriction site (Giachetti and Semler, 1991, 1992). For all
substitutions listed, the complete HRV 14 nucleotide sequences were used to encode the indicated amino acid changes, including silent mutations.
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DIIS or D(III)S RNA, CPE on each infected plate ap-
peared within 2–4 h of that for wild-type virus at 37°C,
indicating that the DIIS and D(III)S mutants had most
likely accumulated reversions or second site mutations that
allowed for more rapid virus growth. Consistent with this
possibility, P1 titers for all nine of the mutant virus stocks
used for Northern blot analysis (see below) ranged from 1.6
 108 to 7  108 PFU/ml. To initially confirm the main-
tenance of the HRV14 substitutions and to identify any
reversions or mutations that may have accumulated, the
virus population from infection by each isolate was se-
quenced within the 3AB hydrophobic domain using asym-
metric RT-PCR followed by dideoxy sequencing. The re-
sults of the sequence analysis are presented in Fig. 3.
Sequencing revealed consistency between members of a
pair of isolates, indicating that the nucleotide changes were
not the result of polymerase errors introduced during the
reverse transcription or PCR amplification. Nucleotide
changes that appeared ambiguous (representing possible
sequencing artifacts or heterogeneity in the quasispecies
population) were observed, but not listed. All of the amino
acid changes shown were the result of single adenosine-to-
guanosine transitions (per codon) except for the leucine-to-
serine codon changes in DIIS isolates 6.1 and 6.2, which
were transitions from uracil to cytosine.
For the DIS mutation, no complete reversions of any
Fig. 2. Analysis of translation and replication properties using the coupled in vitro translation/replication assay. (A) shows the translation and protein
processing profiles of each of the indicated RNAs. Proteins were labeled with [35S]methionine. The reaction in lane 1 was not programmed with any PV RNA,
while lanes 2 through 5 were programmed with 250 ng of each individual RNA (per 10 l reaction). Half of each translation reaction was then subjected
to electrophoresis on a 12.5% polyacrylamide–SDS gel and subsequent fluorography prior to exposure to film. (B) shows the corresponding in vitro RNA
replication reactions in which RNAs synthesized in the cell-free extracts were labeled by incorporating [32P]CTP. The reaction in lane 2 was not
programmed with any PV RNA, while lanes 3 through 6 were programmed with each of the respective RNAs. As a gel loading control, (C) shows the same
gel as in (B) after staining with ethidium bromide to detect ribosomal RNAs (28S RNA) as well as virion RNA (ss vRNA) from poliovirus. In a separate
experiment, PV1 RNA was translated and replicated in the presence of 2 mM guanidine HCl, in which PV translation proceeded unimpaired while RNA
replication was completely inhibited (data not shown).
Table 1
Summary of RNA transfections
Type of RNA RNA transfected per 60-mm dish (g)
5.0 0.5 0.05 0.005
Wild-type All cells dead All cells dead 100 plaques 10–15 plaques
DIS All cells dead All cells dead 100 plaques 5–10 plaques
DIIS 5–10 plaques 1–2 plaques No plaques No plaques
D(III)S 5–10 plaques No plaques No plaques No plaques
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nucleotides encoding the hydrophobic domain were seen
(partial, 50%, adenosine-to-guanosine transitions were
seen for all six secondary isolates, a change that would
revert the threonine 65 to the PV alanine), a result consistent
with the high-specific infectivity of the RNA compared to
that of DIIS or D(III)S.
Substitution of domains III of HRV14 into poliovi-
rus resulted in RNA with the lowest specific infectivity.
Sequence analysis revealed that all six isolates consis-
tently contained at least one first position nucleotide
change resulting in the reversion of threonine at position
65 to the PV alanine. In addition, isolates 7.1 and 7.2
each contained a first position change causing the RNA to
code for the PV amino acid valine instead of isoleucine at
position 75. Isolates 8.1 and 8.2 each harbor two separate
amino acid changes in addition to two silent third posi-
tion changes. One of the third position changes is outside
the hydrophobic domain in the codon for glutamic acid
53 in 3A, while the other silent mutation is the same third
position change seen in the DIIS isolates 4.1 and 4.2
(leucine 73). The most striking feature of the D(III)S
substitution is the consistent need for an alanine at posi-
tion 65 as illustrated by the fact that all six isolates
contained the same nucleotide change.
Sequence analysis of the DIIS isolates also revealed
nucleotide mutations resulting in codon changes. Isolates
4.1 and 4.2 contained a first position change resulting in a
reversion of isoleucine 75 to the PV valine, while isolates
6.1 and 6.2 each had a second position change resulting in
the substitution of leucine 73 to the noncanonical amino
acid serine. Curiously, isolates 4.1 and 4.2 each contained a
third position change (adenosine to guanosine) in which the
substituted amino acid (leucine) was maintained. Finally,
the most interesting sequence results were obtained from
DIIS isolates 5.1 and 5.2. The initial sequence analysis
indicated that neither isolate contained any sequence
changes throughout the entire 3AB coding sequence. The
inability to find any nucleotide changes in these DIIS iso-
lates, combined with the very low specific infectivity of the
DIIS RNA, suggested the accumulation of a mutation(s)
outside of the 3AB coding region. Indeed, a second site
mutation was discovered when the complete genomes of
both isolates 5.1 and 5.2 were sequenced. To this end, five
overlapping RT-PCR fragments that span the entire polio-
virus genome were sequenced. The results of this analysis
are shown in Table 3. Some mutations outside of 3A were
found in one isolate but not the other and represent nucle-
otide changes introduced by either the virus following the
first round of plaque purification or polymerase errors dur-
ing the subsequent genome amplification by RT-PCR. How-
ever, one mutation, C3930U, was found in both isolates and
likely represents a virus-selected mutation that occurred
early in the replication cycle of the virus that confers in-
creased virus fitness in infected tissue-culture cells. This
second site reversion results in a threonine-to-isoleucine
change in amino acid number 33 of poliovirus protein 2B
and provides novel genetic data that suggest 3A(B) and 2B
may directly interact within the replication complex.
Analysis of RNA synthesis in virus-infected HeLa cells
To determine if the nucleotide sequence changes de-
scribed above were responsible for increased viral RNA
synthesis in infected cells, levels of virus-specific RNA
accumulation were measured. Passage 1 virus stocks were
used to infect HeLa cells at 37°C followed by the harvest of
total cellular RNA at 0, 2, 4, and 6 h postinfection. The
levels of PV-specific positive-strand RNA accumulation
were measured by Northern blot analysis using a mixture of
negative-strand oligonucleotide probes. As shown in Fig. 4,
the kinetics of RNA accumulation for viruses containing the
domain I substitution (DIS) were significantly delayed com-
pared to those of wild-type virus (top panel, compare lanes
2, 6, and 10 to lane 14). The isolates containing the domain
II substitutions (DIIS) contain multiple mutations and re-
versions within the HRV14 substituted sequences. These
sequence variations do not produce dramatic differences in
the kinetics of RNA accumulation (shown in the middle
panel of Fig. 4) when compared to each other. However, all
three DIIS isolates showed delayed rates of RNA accumu-
lation compared to that of wild-type. Finally, for the mu-
Table 2
Summary of virus isolates containing 3AB hydrophobic domain
substitutions
RNA Primary
isolate no.
Secondary
isolate no.
Northern
blot analysis
DIS (24 h) 1 1.1 Yes
1.2 No
2 2.1 No
2.2 Yes
3 3.1 Yes
3.2 No
DIIS (48 h) 4 4.1 Yes
4.2 No
5 5.1 Yes
5.2 No
6 6.1 Yes
6.2 No
D(III)S (72 h) 7 7.1 Yes
7.2 No
8 8.1 Yes
8.2 No
9 9.1 Yes
9.2 No
Note. Three well-isolated plaques for each RNA were picked using a
sterile Pasteur pipette and placed in MEM. The primary plaques were then
diluted serially and used to infect HeLa monolayers at 37°C for the purpose
of picking secondary plaques. Two secondary plaques were picked per
primary isolate. One secondary isolate was then used to generate passage
1 and passage 2 virus stocks, which were subsequently used to infect HeLa
cells to analyze the kinetics of RNA accumulation by Northern blot
analysis. Shown in parentheses next to the name for each RNA is the
approximate time for CPE to be observed in HeLa cells (with liquid culture
overlays) transfected with 5 g of the corresponding RNA.
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tants containing the domain III substitutions [D(III)S],
the kinetics of RNA accumulation were even more delayed
compared to those of wild-type than any of the DIS or DIIS
mutants. This can be seen by comparing lanes 2, 6, and 10
to lane 14 (bottom panel) as well as by observing the
reduced levels of RNA present at 4 h after infection com-
Fig. 3. Summary of the sequence analysis for each of the virus isolates. Shown on the top line is the amino acid sequence of the PV1 hydrophobic domain.
Dashes indicate identity of the amino acid at that position with that of PV1. Amino acids different from those of PV1 are listed in the line corresponding
to the sequence of each isolate. Amino acids in parentheses indicate that a nucleotide mutation was detected in that codon. The asterisks next to D(III)S
isolates 8.1 and 8.2 indicate that the sequence analysis detected a third position change (A to G) in the codon for glutamic acid at position 53 of 3A.
Table 3
Summary of complete genomic sequencing of mutant PV1-3AB-DIIS 5.1 and 5.2
PCR fragment (PV1 nucleotides) Nucleotide change Codon change Amino acid change Comments
DIIS isolate 5.1
Segment 1 (23–1023) U761A UCA to ACA Ser to Thr Not in isolate 5.2
Segment 2 (625–2879) None
Segment 3 (2615–4326) C3930U ACC to AUC Thr to Ile Primary plaque mutation
Segment 4 (3995–6074) G4910A GCC to ACC Ala to Thr Not in isolate 5.2
Segment 5 (5480–7432) None
DIIS isolate 5.2
Segment 1 (nt 23–1023) None
Segment 2 (625–2879) U2035C CUU to CCU Leu to Pro Not in isolate 5.1
Segment 3 (2615–4326) C3930U ACC to AUC Thr to Ile Primary plaque mutation
A3960G AAC to AGC Asn to Ser Not in isolate 5.1
Segment 4 (3995–6074) None
Segment 5 (5480–7432) None
Note. Total RNA from cells infected with P1 stocks of isolates 5.1 and 5.2 were harvested and used to generate five overlapping RT-PCR fragments which
were subsequently sequenced as described under Materials and methods. The U761A change corresponds to sequences in VP4, the U2035C change to
sequences in VP3, the C3930U and A3960G changes to sequences in 2B, and the G4910A change to sequences in 2C. There are also a number of nucleotide
changes common to both isolates that are in the full-length laboratory clone which are different from one of the published PV1 genome sequences (Kitamura
et al., 1981; Racaniello and Baltimore, 1981). Those changes are U2308C, A3043G, C4174A, and C6261U. Bold notation indicates relevant second-site lesion
in protein 2B coding region.
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pared to that at 6 h. For all of the DIS and DIIS mutants, the
RNA levels at 4 h postinfection were nearly identical to
those at 6 h. By contrast, cells infected with the D(III)S
mutants had significantly reduced RNA levels at 4 h after
infection compared to those seen at 6 h.
Discussion
In this study, we have provided evidence for the partial
conservation of function of the 3AB hydrophobic domain
between members of the picornavirus entero- and rhinovirus
Fig. 4. Northern blot analysis of DIS, DIIS, and D(III)S mutants. HeLa suspension cells were infected at an m.o.i. of 10 using the passage 1 stock
of the indicated virus isolate. At each of the indicated times after infection, total cellular RNA was harvested. Ten micrograms of total RNA was
denatured and subjected to electrophoresis through a 1.1% agarose sodium phosphate gel. PV positive-strand RNA was detected using a mixture of
three negative-strand oligonucleotides specific for the 2C coding sequences. As controls, total RNA from mock-treated HeLa cells was harvested at
0 and 6 h. The mobility of the 7.5 kb PV RNA is denoted by an asterisk in which the marker lane (lane 19) contained 100 ng of PV virion RNA
that was treated in parallel with the other RNAs. The top panel shows the analysis of DIS virus isolates, while the middle panel indicates that of DIIS.
D(III)S isolates are shown in the bottom panel.
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genera. Substitution of the amino half (domain I) of the
poliovirus 3AB hydrophobic domain with the analogous
sequences of HRV14 resulted in a mutant virus that has a
significant RNA replication defect in addition to a slight
defect in P3 protein processing. It is difficult to quantify the
effects of the processing abnormality; however, it is note-
worthy that the level of the viral 3D RNA polymerase is
also reduced. Based upon the transfection data, substitution
of the domain II or domain III sequences results in RNAs
with reduced specific infectivities compared to those of
wild-type or DIS RNAs. Substitution of the domain II se-
quences alone caused a severe replication defect, providing
strong evidence for non-interchangeability of this domain.
This result is somewhat surprising in that, relative to the
domain I substitution, there are fewer amino acid changes
present in the domain II substitution. In addition, the hy-
drophobicity of domain II is very well conserved, which
might predict that the exchange of such sequences should be
the least severe (Giachetti and Semler, 1990; Towner et al.,
1996). Taken together, these experiments suggest that do-
main I of protein 3AB is more functionally conserved be-
tween rhinovirus and poliovirus than domain II. We suggest
that sequences present in domain II could be involved in a
higher order structure which is not tolerant of amino acid
substitutions or that these sequences are involved directly or
indirectly in the formation of a protein interface.
The possibility that the DIIS and D(III)S mutants har-
bor compensatory nucleotide changes outside of the 3A
coding sequences was suggested by a number of observa-
tions. The in vitro replication data demonstrated that both
DIIS and D(III)S display severe RNA replication defects,
especially for D(III)S; yet the Northern blot analysis in-
dicated that all of the corresponding mutant viruses have
delayed, but much less debilitating RNA synthesis defects.
Consistent with the increased fitness by the domain II con-
taining mutants is that infection of HeLa monolayers at an
m.o.i. of 10 required only 1.5 – 2 h longer to effect a similar
level of CPE as wild-type virus infected at an identical
m.o.i. The substantial primary defects in virus replication
are also supported by the RNA transfection data in which
virus plaques were seen only on monolayers receiving the
highest amount of RNA (5 g). This is in contrast to
transfection of DIS RNA which resulted in similar numbers
of plaques using 100 to 1000 times less RNA. The strongest
evidence for the requirement of compensatory mutations
comes from the analysis of DIIS isolates 5.1 and 5.2, which
do not contain any nucleotide changes throughout the 3AB
coding region. Complete genome sequence analysis re-
vealed an identical change in both isolates that confers an
amino acid substitution in poliovirus protein 2B. The over-
all significance of this finding is not yet clear, but it is
tempting to speculate that this suggests a direct protein–
protein interaction between 3AB (or 3A) and 2B within the
replication complex and that such an interaction was per-
turbed by the substitution with the HRV14 sequences but
restored by the compensatory change in 2B. The role of
protein 2B in poliovirus RNA synthesis and replication
complex formation has been previously demonstrated by a
study in which three separate mutations in 2B conferred
noncomplementable defects in RNA synthesis (Johnson and
Sarnow, 1991). In addition, sequence motifs have been
identified in coxsackievirus protein 2B that are important
for viral RNA synthesis (Van Kuppeveld et al., 1995, 1996).
Of particular interest is the report that recombinant coxsack-
ievirus B3 (CVB3) genomes containing PV1/CVB3 chi-
meric 2B proteins expressed altered RNA replication phe-
notypes, depending upon which part of the 2B protein
maintained the CVB3 sequences (Van Kuppeveld et al.,
1997). The authors of this study also suggested that a se-
quence-specific interaction between amino acid sequences
in the carboxy-terminal two-thirds of protein 2B and an
unidentified viral protein may be required for at least one of
the 2B RNA replication functions.
Third position codon changes seen in isolates 4.1/4.2 and
8.1/8.2 provide evidence for the intriguing possibility that
some of the nucleotide substitutions may exert their effects
at the level of RNA secondary structure and not necessarily
at the amino acid level. In a report by de la Torre et al.
(1992), the authors noted that a computer folding of a
150-nucleotide segment of the 3AB coding sequences (in-
clusive of the hydrophobic domain) predicts the formation
of an extensive stem-loop structure with a G° of 38.8.
The idea that RNA secondary structure present within the
coding sequences of positive-strand RNA viruses has func-
tional significance for virus replication is not without pre-
cedent (e.g., Novak and Kirkegaard, 1994; Kim and
Makino, 1995; Reynolds et al., 1995; Frolov and
Schlesinger, 1996; McKnight and Lemon, 1998; Goodfel-
low et al., 2000; Paul et al., 2000; Yang et al., 2002).
Furthermore, in the report by de la Torre and colleagues
(1992), the authors directly examined the reversion frequen-
cies of silent and codon-changing nucleotide substitutions
within the hydrophobic domain of poliovirus protein 3AB.
The authors discovered an apparent ability for the viral
polymerase to simultaneously revert multiple third position
(silent) changes (all transitions) despite the fact that the
reversion of such nucleotides provided no measurable
growth advantage in tissue culture over that of wild-type
PV1. Thus, the replicase machinery is certainly able to
simultaneously incorporate multiple nucleotide changes.
The data reported here suggest that there is a significant
degree of conservation of protein structure/function be-
tween the entero- and rhinoviruses since virus was recov-
ered from RNAs containing all three domain substitutions.
For the most part, these substitutions did not produce 3AB
structure or function exactly equivalent to that of wild-type
PV1, since compensatory sequence changes were often re-
quired for efficient virus growth. Additionally, the results of
this study warrant a more comprehensive analysis of the
domain II containing virus isolates to determine by genome
reconstruction if the discovered sequence reversions are
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sufficient to relieve the replication and/or protein processing
defects conferred by the HRV14 domain substitutions.
Materials and methods
Construction of HRV 14/PV1 hydrophobic domain
substitutions
The cloning scheme for mutagenesis of the hydrophobic
domain of poliovirus protein 3AB has been previously de-
scribed (Giachetti and Semler, 1991; Giachetti et al., 1992),
in which the genetically engineered PstI site at PV nt 5301,
the BglI site at PV nt 5321, and the genetically engineered
HindIII site at PV nt 5351 were digested in pairwise com-
binations to introduce annealed oligo cassettes encoding the
corresponding HRV14 sequences. The cassette used for the
domain I substitution was the oligo 5-GACTATTCTGAT-
GTTTGTCAGTG-3 annealed to the oligo 5-CACAGA-
CAAACATCAGAATAGTCTGCA-3; the cassette used
for the domain II substitution was the oligo 5-CAACAT-
TAGGTATTGTTTATGTCATTTATA-3 annealed to the
oligo 5-AGCTTATAAATGACATAAACAATACCTA-
ATGTTG-3; and finally, the cassette for the domain III
substitution was made by annealing the oligonucleotides
5-GACTATTCTGATGTTTGTCAGTACATTAGGTATT-
GTTTATGTCATTTATA-3 and 5-AGCTTATAAATGA-
CATAAACAATCCATAATGTACTGACAAACATCAG-
AATAGTCTGCA-3. Note that for the domain I and
domain II substitutions, the BglI site was blunt-ended using
T4 DNA polymerase prior to ligation.
RNA transcription, RNA transfection, and plaque assays
RNA transcriptions were performed essentially as de-
scribed (Towner et al., 1996) with the following changes:
(a) the plasmids were linearized with EcoRI and (b) RNAs
used for transfections were not extracted with phenol/chlo-
roform or ethanol precipitated but were used in crude form
following the 37°C incubation. The RNA transfections were
performed using DEAE-dextran following the procedures
outlined in Charini et al. (1991). Plaque assays were per-
formed in 60-mm-diameter dishes under semisolid media at
33 or 37°C for the indicated amount of time. Dishes were
then overlaid with 10% trichloroacetic acid for 45 min,
followed by staining with crystal violet prior to plaque
counting.
Analysis of RNA by Northern blot
Total cytoplasmic RNA was harvested by the method of
Favaloro et al. (1980) with previously described modifica-
tions (Roehl et al., 1993). Northern blot analysis was per-
formed by resolving 10 g of glyoxylated total cellular
RNA on a 1.1% agarose gel in 10 mM sodium phosphate
buffer (McMaster and Carmichael, 1977) and transferring
the RNA to a GeneScreen membrane (DuPont). The blot
was then probed with a mixture of the 5 end-labeled,
negative-strand oligonucleotide probes JT2C4864 (com-
plementary to PV nt 4845–4864), JT2C4588 (comple-
mentary to PV nt 4569–4588), and JT3A5130 (comple-
mentary to PV nt 5110–5130), which are specific for the
sequences of the poliovirus 2C region.
Sequencing of recovered viruses
Sequencing of viral RNA encoding the carboxy-terminal
half of 3A was performed by first amplifying the entire 3AB
sequence by RT-PCR (50 l total volume) using the primers
CGS1 (anneals to sequences in VPg; Giachetti and Sem-
ler, 1991) and JT2C5060 (anneals to PV nt 5060–5080).
A portion (3 l) of each RT-PCR reaction was then used in
an additional 50 l PCR reaction in which only the primer
JT2C5060 was provided, such that a positive-sense sin-
gle-stranded DNA was asymmetrically amplified. Follow-
ing asymmetric PCR, each reaction was passed through a
Sephadex G-50 column to remove unincorporated oligonu-
cleotides and dNTPs. Approximately half of each reaction
was then used for dideoxy sequencing using the primer
CGS1 and phage T7 DNA polymerase. Sequencing of the
complete genomes of DIIS isolates 5.1 and 5.2 was carried
out by amplifying by RT-PCR five overlapping domains
spanning the entire poliovirus genome (see Table 3 for the
nucleotide numbers of each RT-PCR fragment). Each RT-
PCR product was gel purified prior to automated sequence
analysis by the UC Irvine Automated DNA Sequencing
Core Facility or Biotech Diagnostic, LLC (Laguna Niguel,
CA).
Coupled in vitro translation/replication assays
Assays were performed essentially as described in Todd
et al. (1997), in which the HeLa ribosomal salt wash (RSW)
preparation was performed as described by Brown and
Ehrenfeld (1979), and the HeLa S-10 extract preparation
was performed as described by Barton et al. (1995). Minor
differences or new modifications in either the extract prep-
aration or the translation/replication assay are outlined as
follows: (a) HeLa cells were resuspended in hypotonic
buffer in a volume equal to 120% of that of the cell pellet
volume; (b) each replication reaction contained 51% (v/v)
HeLa S-10, 18% (v/v) RSW preparation, 21% (v/v) DEPC-
treated H2O, and 10% (v/v) of a 10 mix containing (at
10) 10 mM ATP, 2.5 mM GTP, 2.5 mM UTP (no CTP
was added), 600 mM potassium acetate, 300 mM creatine
phosphate, 4 mg/ml creatine kinase, and 155 mM HEPES-
KOH (pH 7.4); (c) reaction mixtures (50 l), programmed
with in vitro transcribed RNA (9.6 nM), were divided into
portions containing 10 and 40 l. The 10-l portions [con-
taining an additional 10.5 Ci [35S]methionine (Amersham)
at 1000 Ci/mmol] were used for analysis of translation
and protein processing, while the 40-l reaction was used
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for analysis of RNA synthesis. All reactions were incubated
for 6 h at 30°C, at which time the translation reactions were
diluted in Laemmli sample buffer (Laemmli, 1970), boiled,
and subjected to SDS–polyacrylamide gel electrophoresis
on a 12.5% gel. The replication reactions were subjected to
centrifugation at 15,000 g for 15 min at 4°C and subse-
quently resuspended in 5 l of buffer (50 mM HEPES pH
8.0, 3 mM MgCl2, 10 mM DTT, 0.5 mM each of ATP, GTP,
and UTP) containing 25 Ci of [-32P]CTP and incubated
for an additional hour at 37°C. Total RNA was then ex-
tracted from each sample using phenol:chloroform (1:1),
ethanol-precipitated, and resuspended in DEPC-treated
H2O. Total RNA was then subjected to gel electrophoresis
on a 1.1% agarose TBE gel containing ethidium bromide. In
an adjacent lane,500 ng of vRNA was loaded as a marker
to visualize the mobility of single-stranded poliovirus RNA.
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